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Abstract 
Background: Familial cancer includes some types of cancer aggregation without a well-defined inheritance pattern. 
Cancer genetics is an essential component of clinical practice in oncology. In Brazil, breast cancer is the leading cause 
of death in women. In Maranhão, studies on genetic predisposition are necessary to investigate the incidence and 
mortality rates. The aim of this study was to investigate familial cancer among relatives of women who died of breast 
cancer in São Luís, Brazil, constructing a pedigree to identify families with a hereditary predisposition, an important 
step in the early diagnosis of malignant tumors.
Methods: The city of São Luís is located on the Island of Maranhão, northeastern Brazil, with a population of 997,098 
inhabitants mainly comprising blacks and mulattoes, including descendants of runaway slaves from the Amazon 
region itself. Data for pedigree construction were obtained from the records of 54 patients seen at the Aldenora Bello 
Institute of Oncology, São Luís, between 2000 and 2007, as well as by interview with relatives of the patients.
Results: The mean patient age at diagnosis was 39.5 years. Most women were mulattoes (36/54, 66.6 %). A history of 
cancer was observed in 18 families, with 16 families possessing cases of cancer among first-degree relatives and five 
among second-degree relatives.
Conclusion: A concentration of cancer cases was found in families of patients diagnosed until the age of 40, a find-
ing demonstrating the importance of a family history prior to genetic counseling.
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Background
Breast cancer is the second most frequent type of can-
cer in the world and the most common among women. 
The highest rates are observed in North America and in 
South American countries such as Brazil and Argentina 
[1]. In Brazil, estimates for 2014 indicated 57,120 new 
cases of breast cancer, including 570 in the State of Mara-
nhão and 250 of them in the municipality of São Luís [2].
Data from the Brazilian Institute of Geography and Sta-
tistics (IBGE) showed that life expectancy at birth in Bra-
zil increased from 74.6 to 74.9  years in 2014. The State 
of Maranhão has a life expectancy of 69.7 years; 66 years 
for men and 73.7 years for women. In Maranhão, access 
to health services is still difficult, because of the low eco-
nomic status of the population and the lack of public pol-
icies for the organization of health care [3].
Hereditary cancer comprises diverse syndromes that 
are relatively rare and of monogenic etiology. These syn-
dromes are estimated to correspond to about 5–10 % of 
cancer cases in the general population [4, 5]. An elevated 
risk of breast cancer in first- and second-degree relatives 
of patients with an apparently sporadic cancer has been 
reported in various population studies [4, 6–8]. Genetic 
factors predisposing to hereditary cancer are believed to 
be responsible for 5.0–7.0 % of all cases of breast cancer. 
Hereditary cancer syndromes lead to the occurrence of 
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disease at a younger age than that of the population with 
sporadic breast cancer, with approximately 25.0  % of 
cases being diagnosed before the age of 40 [9, 10]. Other 
studies have reported an increased risk of breast cancer 
among individuals younger than 50 and 60 years, respec-
tively [6, 11]. Women who inherit a loss-of-function 
mutation in one of the alleles of the BRCA1 or BRCA2 
genes present a 85.0  % higher risk of developing breast 
cancer until the age of 70 [11, 12].
Analysis of cancer family history may reveal the exist-
ence of various other cases of disease with peculiar char-
acteristics, such as relatives affected in three successive 
generations, two or more first-degree relatives with a 
premenopausal diagnosis of the disease, cases of bilateral 
breast cancer, and cases of breast cancer in men [13].
National Institute for Health and Clinical Excellence 
(NICE) guidelines recommend the use of information 
from family history, which should be taken into account 
in assessing risk and deciding whether and when to refer, 
and when to reassure [14]. Women with increased risk 
based on a positive family history as described within 
NICE guidelines may be advised to undergo a range of 
different forms of surveillance, genetic testing or even 
preventive management [15].
The definition of the form of tracking high-risk women 
have not yet supported on current scientific evidence 
and is varied to approach this group in national screen-
ing programs. It is recommended that women at high risk 
of breast cancer have individualized clinical monitoring. 
The National Institute of Cancer of Brazil (INCA) recom-
mends screening for women at high risk of breast cancer, 
whose routine should start at age 35 with breast exami-
nation and annual mammography [16].
With respect to the histopathological classification 
of breast tumors, a predominance of infiltrating ductal 
carcinoma is observed, which accounts for 65.0–85.0  % 
of these malignant tumors. However, the relationship 
between histological type and hereditary cancer is still 
not well established [17–19].
Family health history has long been acknowledged as 
an important part of the medical examination [20]. In 
breast cancer, family history is a key risk factor of breast 
cancer [21–23]. Women with a strong family history of 
breast cancer could inherit genetic alterations that mod-
ify their risk of disease [24]. Study conducted in Spain 
showed that 20  % of invasive breast carcinomas had a 
family history of cancer [25].
Primary care has an important role in the prevention 
and early diagnosis of hereditary cancer. Reduction in 
risk through prevention is a core function of primary care 
[26].
In Brazil, genetic tests are still not available through the 
public health service and the construction of pedigrees is 
therefore important for the investigation of cases of can-
cer among relatives. The possibility of identifying rela-
tives who are at high risk for the development of cancer 
permits the application of preventive measures and the 
early detection of cancer. Patients classified as high risk 
according to cancer family history could be referred for 
genetic counseling at other centers of the country.
In view of the lack of studies on this subject in the State 
of Maranhão, the objective of the present investigation 
was to evaluate the occurrence of malignant tumors in 
first- and second-degree relatives of patients with a diag-
nosis of breast cancer who died before the age of 60.
Methods
An observational, descriptive study divided into two 
phases was conducted: a retrospective study reviewing 
the records of 54 patients from São Luís who had died of 
breast cancer before the age of 60 and had a histopatho-
logical exam revealing a malignant breast tumor and a 
prospective study interviewing relatives for the collec-
tion of information about cancer history in these fami-
lies. Since according to the literature, hereditary cancer 
syndromes, especially Li-Fraumeni syndrome, affect indi-
viduals with one first- or second-degree relative with a 
typical tumor of this syndrome identified at any age and 
with another first- or second-degree relative with cancer 
diagnosed before the age of 60 [27]. Due to this informa-
tion, this age was adopted as an inclusion criterion.
The study involved 54 women who lived at São Luís—
MA seen at the Aldenora Bello Maranhense Institute of 
Oncology (IMOAB) between 2000 and 2007. This service 
is certified as a Reference Center of High Complexity in 
Oncology (CACON). In the analyzed period, there were 
158 deaths due to breast cancer, but were recruited only 
women’s medical records residing in São Luís, so only 
54 were included. This is a convenience sample from the 
158 recorded deaths. Because of the difficulty of recruit-
ing relatives of women who resided in the State of Mara-
nhão, only 54 women were included because they lived 
in São Luis. Family members were invited to participate 
in the study and after signing an informed consent were 
included. All family members agreed to participate in 
the study and there was no loss to follow-up during the 
period.
The following characteristics of morbidity and mor-
tality were analyzed: age at diagnosis and death, overall 
survival, tumor laterality, tumor stage, associated tumors, 
and presence of metastases. The presence of other cancer 
cases in the family, number of affected relatives, degree 
of kinship, and other types of malignant tumors observed 
in the family until the third generation were also inves-
tigated. The recommendations of the National Compre-
hensive Cancer Network and of the project Guidelines 
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for Hereditary Cancer were used as criteria of heredi-
tary cancer [4, 27]. Parents, siblings and sons/daughters 
of index cases were defined as first-degree relatives, and 
uncles/aunts and grandparents were defined as second-
degree relatives [28].
Sociodemographic data, histopathological type, hand-
edness when it comes to breast cancer, staging, overall 
survival and site-metastatic were obtained by review of 
medical records.
The study was approved by the Research Ethics Com-
mittee of the University Hospital, Federal University of 
Maranhão (No. 362/07). The Statement of Informed Con-
sent Form (ICF) was presented to the families of women 
who died from breast cancer and signed in obedience for 
Resolution No. 196/96 and its complementary. The infor-
mation contained in pedigrees obtained maintains the 
confidentiality of the study patients and their families.
The data were tabulated using the Microsoft Excel 2003 
program and analyzed with the Epi-Info 2007 program, 
version 3.4.3.
Results
A total of 158 deaths due to breast cancer were observed 
among women aged 60  years or younger between 2000 
and 2007. Fifty-four women with breast cancer who lived 
in São Luís—MA were studied.
The age of these women at the diagnosis ranged from 
a minimum of 22 years to a maximum of 60. The mean 
age was 39  years and 6  months, with a standard devia-
tion of 7.52 and the average (age of ) death of 41.98 years, 
with a standard deviation of 7.91 age. The demographic 
data presented in Table 1 show that the vast majority of 
women was of mixed race (n = 36/54, 66.6 %), married 
(or in a stable relationship) (n  =  29/54, 53.7  %). Most 
women (30) studied had reasonable education (second-
ary or higher) (n = 30/54, 55.6 %). It was observed that 
most diagnoses of breast cancer was performed in young 
women aged 30–39 years (55.8 %).
The most common histological type was infiltrating 
ductal carcinoma (83.3  %), followed by the association 
of infiltrating ductal carcinoma/infiltrating lobular carci-
noma (7.4 %). One patient (1.9 %) had lobular carcinoma 
and another (1.9  %) had comedocarcinoma. The right 
breast was the most affected (24/54, 44.4  %). The left 
breast was affected in 21 (38.8 %) patients and 7 (12.9 %) 
presented a bilateral tumor. In the cases studied, there 
were no cases of family history in bilateral cancer, with 
no information being available for two (3.7  %) patients. 
Lymph node involvement was observed in 36 (66.7  %) 
women and all of them developed distant metastases, 
except for one patient. The most frequent metastatic sites 
were bone (23/54, 42.6 %), lungs (19/54, 35.2 %), and liver 
(15/54, 27.8 %) (Table 2).
With respect to tumor stage, there was a predomi-
nance of stage III among the 54 women studied (n = 27; 
50.0 %). Stage II was observed in 13 (24.0 %) women and 
stage IV in 14 (25.93 %) (Table 2). Furthermore, 56.1 % of 
the patients with stage III and IV cancer were between 
30 and 39  years of age at diagnosis and 5.6  % of the 
women with stages III and IV were 29 years or younger 
(Table 3). Eighteen (33.3 %) of the 54 families presented 
a history of cancer (Table 3). Only one case of cancer, in 
addition to the index case, was observed in 13 families 
(72.2 %). Three other families (16.6 %) reported two cases 
of cancer. Among patients with a family history of can-
cer, 61.1 % were diagnosed at age 39 or younger and only 
22.2 % (4/18) of these patients were 50 years or older. The 
malignant tumors identified in the families included lung 
cancer in eight (27.4  %), ovary cancer in four (prostate 
cancer in three (13.7 %), ovary cancer in four and mela-
noma in three (10.3 %).
In this study, overall survival ranged from 1 to 
240  months, with an average of 30.2  months and a 
median of 16  months, and the 5-year survival was 
85.1  %. It is also observed that 11 women with stage II 
Table 1 Sociodemographic characteristics of  women who 
died by breast cancer, IMOAB, 2000–2007, São Luís—MA
Variables Frequency Percent
Age in years
 20–29 4 7.4
 30–39 30 55.8
 40–49 14 25.9
 50–59 5 9.3
 60 1 1.9
Ethnicity
 Black 15 27.7
 White 2 3.7
 Brown 36 66.6
 Not declared 1 1.9
Marital status
 Single 21 38.8
 Married or stable union 29 53.7
 Widowed 0 0.0
 Separated 3 5.5
 Not declared 1 1.9
Education
 No school 1 1.9
 Uncompleted 1° school 18 33.3
 1° school only 5 9.2
 Uncompleted 2° school 0 0.0
 Completed secondary school 23 42.6
 Uncompleted college 1 1.9
 College 6 11.1
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survived two to 48 months (5 years) and only one had to 
240 months. A relationship was observed between tumor 
stage and overall survival, with 85.7 % of the patients with 
initial tumor stage IV and 22.2 % with stage III presenting 
survival less than 12 months (Table 4).
Analysis of first-degree relatives demonstrated the 
occurrence of melanoma in one family involving two 
first-degree relatives, one of them also having a diagnosis 
of breast cancer. Two cases of cancer (prostate cancer and 
melanoma) were observed in another index case. Malig-
nant tumors also occurred sporadically in second-degree 
relatives, with the observation of lung cancer in two fam-
ilies and a case of prostate cancer in another. The distri-
bution of multiple cases of cancer is shown in Table 5. 10 
(71.4 %) families presented two or more cases along two 
generations, three (21.4 %) had two or more cases in the 
same generation, and one reported three cases in three 
generations. Sixteen (37.2  %) families reported cases 
among first-degree relatives of the index case and five 
(11.6 %) among second-degree relatives. Among families 
with a history of cancer, 10 (71.4  %) reported cancer in 
only first-degree relatives, three (21.4  %) exclusively in 
second-degree relatives, and one family had cases among 
first- and second-degree relatives.
An association of breast and ovarian cancer (breast-
ovarian syndrome) was observed in two women (11.1 %, 
2/18) and association of breast and colorectal cancer 
(breast, colorectal syndrome) in a woman (5.5  %, 1/18), 
and other cases (83.3 %, 15/18). Figure 1 shows pedigrees 
of families with breast cancer history and association 
with colorectal cancer (1a) and ovarian cancer (1b). In 
the represented case, the increase is evident in the risk of 
malignancies in patients with these syndromes. Of the 18 
families who reported a history for cancer, two are repre-
sented by pedigrees described in Fig. 2. Figure 2a is a case 
of family history of prostate cancer, which is the most 
Table 2 Clinical characteristics of  women who died 
from breast cancer. IMOAB, 2000–2007, Sao Luis—MA
Clinical characteristics f %
Family history of breast cancer
 No 29 53.7
 Yes 18 33.3
 Not declared 7 13.0
Tumor localization
 Right 24 44.4
 Left 21 38.9
 Bilateral 7 13.0
 Not declared 2 3.7
Histological type
 Invasive ductal carcinoma 45 83.3
 Invasive ductal and lobular carcinoma 4 7.4
 Carcinoma SOE 2 3.7
 Lobular carcinoma 1 1.9
 Invasive ductal carcinoma associated to Paget’s disease 1 1.9
 Comedocarcinoma SOE 1 1.9
Cancer stage
 II 13 24.0
 III 27 50
 IV 14 26.0
Lymph node invasion
 Yes 36 66.7
 No 16 29.6
 Not declared 2 3.7
Metastasis
 Bone 23 42.6
 Lung 19 35.2
 Liver 15 27.8
 Brain 11 20.4
 Pleura 4 7.4
 Others 4 7.4
Table 3 Distribution of  women who died of  breast cancer and  relationship with  a family history of  cancer and  stage 
(IMOAB, São Luís, 2000–2007)
Age range  
(years)
Family history of cancer Stage
No Yes Unknown II III IV
N % N % n % n % N % n %
20–29 1 3.5 2 11.1 1 14.3 1 7.7 2 7.4 1 7.1
30–39 17 58.6 9 50.0 4 57.1 7 53.8 16 59.3 7 50.0
40–49 9 31.0 3 16.7 2 28.6 4 30.8 6 22.2 4 28.7
50–59 2 6.9 3 16.7 0 0.0 1 7.7 3 11.1 1 7.1
60 0 0.0 1 5.6 0 0.0 0 0.0 0 0.0 1 7.1
Total 29 100.0 18 100.0 7 100.0 13 100.0 27 100.0 14 100.0
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prevalent tumor in men in Brazil. Figure 2b shows a case 
of family history of lung cancer, which is a high morbidity 
and mortality tumor.
Discussion
Breast cancer mortality rates continue to be high in Bra-
zil, because in most cases the diagnosis is made during 
a late stage of the disease. According to Abreu and Koif-
man [17], stages III and IV correspond to about 60 % of 
all initial diagnoses. Even higher rates were observed in 
the present study, with 75.9 % of the patients presenting 
stage III and IV cancer. Of these, 5.5 % were women aged 
29 years or younger, a finding that might be explained by 
the fact that there is no routine indication of mammog-
raphy for women of this age, with a consequent delay in 
diagnosis.
Variations in the incidence of breast cancer among 
young women are reported in the literature. In the study 
of Silva [19], 22.3  % of the patients were younger than 
40  years. Oliveira et  al. [29] observed 5.5  % of patients 
aged 35  years or younger and 36.4  % of them reported 
other cases of cancer in the family. In the present study, 
Table 4 Distribution of women seen at IMOAB who died of breast cancer according to tumor stage and its relationship 
with survival (São Luís, 2000–2007) (n = 54)
Stage Survival (months)
1–12 13–24 25–36 37–48 49–60 61–72 73–84 85–96 97–156 157–240 Total
II 2 5 1 3 0 0 0 0 1 1 13
III 6 12 1 3 0 2 2 1 0 0 27
IV 12 0 0 1 0 1 0 0 0 0 14
Total 20 17 2 7 0 3 2 1 1 1 54
Table 5 Distribution of  cases of  cancer in  relatives of  women diagnosed with  breast cancer in  IMOAB. St. Louis, 2000–
2007
a In the same family of the index case was diagnosed cancer in breast and skin
Index case Stage Family
1° and 2° degrees
Lung Prostate Melanoma Ovary Breast Colorectal Stomach Pancreas Larynx Esophagus Uterine 
cervix
1° 2° 1° 2° 1° 1° 2° 1° 2° 1° 1° 1° 1° 2° 2°
1° IV 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
2° IV 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
3° IV 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
4° IV 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0
5° IV 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
6° IV 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7° IIa 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
8° IIIb 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
9° IIIb 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
10° IIIc 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
11° IIa 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
12° IIa 0 0 0 0 2a 0 0 1a 0 0 0 0 0 0 0
13° IIa 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
14° IIIb 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1
15° IV 0 0 0 0 0 0 1 0 0 1 1 0 1 1 0
16° III 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
17° IV 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
18° II 0 1 0 0 0 1 0 0 2 0 0 0 0 0 1
5 3 2 1 3 3 1 1 2 2 3 1 1 1 2
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4/54 (7.4 %) of the patients were diagnosed before the age 
of 29 and 34/54 (62.9  %) before the age of 39. The per-
centage of patients younger than 30 years (7 %) observed 
here was lower than that reported in the study of Oliveira 
et al. [29] in which this age group accounted for 20.0 % of 
cancer cases.
Eisenberg [30], following up women with infiltrat-
ing ductal carcinoma younger than 60  years in the 
State of Rio de Janeiro for 60  months, found a survival 
of 55  months. This finding is in contrast to the present 
investigation [30]. However, deaths that occurred after 
the 60  months of follow-up were not included in that 
study, a fact that might explain this difference. In agree-
ment with the present study, Silva [19] observed a mean 
survival of 39.3  months among women who died of 
breast cancer. The lack of recommendation of mammog-
raphy screening for this age group may explain the late 
diagnosis in young women. Therefore, it is important to 
obtain a family history of cancer during anamnesis.
Several studies have demonstrated a relationship 
between breast cancer and other cancer cases in the fam-
ily, with the prevalence of cancer cases ranging from 5 to 
10.0 % [8, 9, 13, 31, 32]. The prevalence of a family history 
of cancer was high in the present study (33.3  %) with a 
predominance of sporadic cases.
In studies designed to evaluate the relationship 
between a certain type of cancer and a family history of 
this disease, some confounding factors may impair the 
analysis such as a small number of affected subjects and 
difficulties in the confirmation of family history [4]. In 
the present study, most families with a history of cancer, 
including the index cases, presented at least two cases 
of malignant neoplasms. However, confirmation of the 
tumor was not possible in most cases, a fact impairing a 
more accurate analysis of the data collected. On the other 
hand, considering only families with three or more cases, 
the frequency obtained was similar to that reported in 
the literature.
In the study of Vieira [9], the tumors observed in fami-
lies of index cases included colon, rectal and prostate 
cancer, melanoma, and hepatic carcinoma. In the present 
study, the most frequent tumors were lung cancer, pros-
tate cancer, melanoma, and ovarian cancer [9]. Lung can-
cer was the most frequent in these families. However, the 
strong environmental component involved in the genesis 
of this tumor and the impossibility to investigate the life 
habits of these cases did not permit to establish a rela-
tionship with hereditary cancer [33].
Two index cases call attention because of the particu-
larities of their evolution. The first was an association 
Fig. 1 a Pedigree of a family with breast cancer history and association with colorectal cancer. b Pedigree of a family with breast cancer history and 
association with ovarian cancer. Male family members are represented by a square and female by a circle while a line indicates the family member is 
deceased
Fig. 2 a Family history of prostate cancer. b Family history of lung cancer. Male family members are represented by a square and female by a circle 
while a line indicates the family member is deceased
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with pregnancy in a 29-year-old woman. According to 
the patient, nodules arose in her right breast by the sixth 
month of gestation but no appropriate investigation was 
performed. During the puerperium, after treatment for 
mastitis without an adequate response, the diagnosis of 
a malignant breast neoplasm was established. However, 
distant disseminated tumor cells were detected and the 
patient died after only 2  months. The family history of 
this index case showed a case of cervical cancer.
Breast cancer is the second most frequent tumor 
associated with pregnancy and hypertrophy and breast 
engorgement during this period may contribute to a 
delay in diagnosis. However, the disease itself does not 
indicate a poor prognosis. In a series of 15 cases of preg-
nancy-associated breast cancer most patients had locally 
advanced disease at diagnosis but progressed satisfacto-
rily and were free of the disease [34]. We found no study 
in the literature investigating the relationship between 
breast cancer during pregnancy and hereditary cancer 
syndromes.
Another woman aged 50  years at the time of diagno-
sis of breast cancer presented a history of melanoma. The 
patient had been treated but recurrence was observed 
1 year later, after the diagnosis of breast cancer had been 
made. The stage of the breast tumor was IIa and the 
patient died at 52 years, with survival of 25 months. Only 
lymph node involvement was demonstrated.
Limitations of this study are the small number of 
included cases, large account of the women reside in the 
interior of state of Maranhão; Absence of a control group 
of to compare if there was a greater risk of family cancer 
in women who have had breast cancer.
Conclusions
In conclusion, the evaluation of family history of breast 
cancer by pedigree construction permitted the identifi-
cation of family groups with an elevated risk of familial 
cancer. This finding demonstrates the relevance of this 
strategy for primary prevention and early detection of 
breast cancer in the Maranhão population.
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